| Code | 3359D | ||||||||||
| MA number | 44/0007/20-S | ||||||||||
| Product Form: | tbl flm 30x50 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 30 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 27.01.2020 |
| Validity: | 27.01.2025 |
| MA renewed: | Renewal application submitted |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Dasatinib MSN 50 mg_04.2024.pdf
|
| PIL: |
PIL_Dasatinib MSN 50 mg_04.2024.pdf
|
| Safety feature | Yes |
| Data update: | 04.12.2023 |
